RecruitingNCT04949737

Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies

Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies: Helico-MQ Interventional Study

Sponsor

University Hospital Center of Martinique

Enrollment

112 participants

Start Date

Oct 9, 2025

Study Type

OBSERVATIONAL

Conditions

Stomach Neoplasms Gastric Neoplasms Helicobacter Pylori

Summary

Estimating the prevalence of Helicobacter Pylori infection in newly diagnosed stomach cancers in the West-Indies will help to understand the epidemiology of this cancer, which is over-incident in the West Indies compared to France. In addition, the constitution of a biobank (tumor tissues, healthy tissues and serum) will allow to set up in a second time etiological studies to identify other risk factors in particular in connection with the exposure to environmental pollutants to adapt the prevention measures.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Patient over 18 years of age, residing for at least 6 months in Martinique, with a primary diagnosis of gastric cancer
Patient having read the information note and having signed the consent to participate in the study
Patient with social security coverage

Exclusion Criteria5

Refusal to participate
Patient who could not answer the questionnaires
Patient not affiliated to a social security system
Patient not fluent in French
Patient under legal protection (legal protection, guardianship, curators, etc.)

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALHelicobacter Pylori detection

Biopsies will be sent to the referral anatomopathology laboratory. The search for Helicobacter pylori will be performed by immunohistochemistry. An additional blood sample for serological testing will be taken during the initial workup. Additional data will be collected through a questionnaire.